Healwell AI Faces Regulatory Scrutiny Amid Major Growth Opportunity

Canadian regulatory authorities have launched an investigation into WELL Health Technologies, a strategic partner and major shareholder of Healwell AI, creating significant headwinds for the company at a challenging time. While Canadian regulators examine acquisition strategies within the health technology sector, Healwell’s subsidiary Orion Health stands to benefit from a multi-billion dollar market opportunity emerging in New Zealand. This creates a complex situation where regulatory uncertainty clashes with substantial international growth potential.

Healwell’s recent financial performance demonstrates remarkable operational progress despite market concerns. The company reported third-quarter 2025 revenue of 30.4 million CAD, representing a staggering 354 percent increase year-over-year. The healthcare software segment, powered by the Read more...